Gotham Asset Management, LLC - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 182 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
Gotham Asset Management, LLC ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$232,000
-8.7%
4,986
-6.0%
0.01%0.0%
Q2 2020$254,000
-78.2%
5,304
-79.0%
0.01%
-75.0%
Q1 2020$1,164,000
-47.0%
25,300
-30.9%
0.03%
-20.0%
Q4 2019$2,198,000
-9.1%
36,590
-14.4%
0.04%
-7.0%
Q3 2019$2,419,000
+27.1%
42,768
+25.1%
0.04%
+43.3%
Q2 2019$1,903,000
+74.3%
34,182
+58.0%
0.03%
+87.5%
Q1 2019$1,092,000
+405.6%
21,632
+303.1%
0.02%
+433.3%
Q4 2018$216,000
-69.4%
5,366
-47.4%
0.00%
-70.0%
Q3 2018$707,000
-35.0%
10,203
-29.0%
0.01%
-37.5%
Q2 2018$1,087,000
+21.0%
14,369
-15.7%
0.02%
+23.1%
Q1 2018$898,000
-67.8%
17,044
-67.4%
0.01%
-68.3%
Q4 2017$2,791,000
-73.6%
52,241
-70.5%
0.04%
-73.5%
Q3 2017$10,564,000
-23.6%
177,136
+1.1%
0.16%
-20.1%
Q2 2017$13,823,000
+14.9%
175,214
+20.8%
0.19%
+26.8%
Q1 2017$12,027,000
+73.4%
145,012
+65.9%
0.15%
+71.9%
Q4 2016$6,937,000
+151.1%
87,429
+121.5%
0.09%
+147.2%
Q3 2016$2,763,000
+80.4%
39,478
+108.4%
0.04%
+176.9%
Q2 2015$1,532,00018,9450.01%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q1 2019
NameSharesValueWeighting ↓
Euclidean Technologies Management, LLC 72,263$2,112,2472.01%
Krensavage Asset Management, LLC 114,825$3,3561.04%
Smith, Graham & Co., Investment Advisors, LP 231,222$6,758,6190.83%
TANG CAPITAL MANAGEMENT LLC 118,857$3,474,1900.50%
Capital Impact Advisors, LLC 12,704$371,3380.36%
BRANDES INVESTMENT PARTNERS, LP 416,177$12,164,8540.34%
Watershed Asset Management, L.L.C. 9,148$267,3960.34%
Jackson Creek Investment Advisors LLC 25,171$7360.33%
SummerHaven Investment Management, LLC 17,608$514,6820.31%
Campbell & CO Investment Adviser LLC 22,547$659,0490.16%
View complete list of EAGLE PHARMACEUTICALS INC shareholders